Understanding the Numbers: A Look at Global and National Data
When answering the question of how many people use drugs, it is important to distinguish between global and national reporting. International bodies like the United Nations Office on Drugs and Crime (UNODC) collect data on a worldwide scale, while national surveys, such as the National Survey on Drug Use and Health (NSDUH) conducted by SAMHSA in the U.S., provide more specific domestic insights. Both sources measure different timeframes, such as lifetime use versus use within the past year or month, which impacts the final figures.
Global Drug Use: Insights from the UNODC
Key findings from the UNODC's World Drug Report in June 2025 indicated that approximately 316 million people globally used drugs in the past year, marking an increase over the preceding decade. This growth suggests that a larger percentage of the world's population is now using drugs. Cannabis remains the most used drug globally, with an estimated 244 million users in 2023. Opioids were used non-medically by about 61 million people in 2023 and contribute significantly to drug-related harm. Synthetic drug and cocaine markets also saw rapid expansion in 2023.
U.S. Drug Use: A Closer Look at the National Landscape
According to the 2023 National Survey on Drug Use and Health (NSDUH), 16.8% of Americans aged 12 or older (47.7 million people) used an illicit drug in the past month. Marijuana was the most used illicit drug, with 61.8 million people (21.8%) aged 12 or older using it in the past year, and 43.6 million in the past month. In 2023, 48.5 million Americans aged 12 or older had a substance use disorder (SUD). More than half of Americans aged 12 or older have used illicit drugs at least once in their lifetime.
Prevalence by Age Group and Gender
Data shows varying drug use rates among different demographics. Young adults aged 18 to 25 typically have the highest rates of past-month illicit drug use (39% in 2023), compared to those aged 26 and older (23.9%). Initiating illicit drug use before age 15 increases the likelihood of developing an SUD. Males generally report higher rates of illicit drug use and prescription drug misuse, although the gender gap is narrowing for some substances in certain regions. Geographically in the U.S., drug use appears slightly more common in larger metropolitan areas.
Understanding the Drug Use Landscape: Key Data Comparison
This table highlights the difference in reporting between a recent UNODC global survey and the 2023 U.S. NSDUH.
Metric | Global (UNODC 2025, 2023 data, age 15-64) | U.S. (NSDUH 2023, past month data, age 12+) |
---|---|---|
Overall Drug Use | ~316 million (past year) | 47.7 million (illicit) |
Cannabis Users | ~244 million (past year) | 43.6 million (past month) |
Opioid Users | ~61 million (non-medical, 2023) | ~8.9 million (misuse, 2022 data) |
Trends and Public Health Impact
Recent data indicates evolving trends and significant public health consequences. While overdose deaths involving synthetic opioids like fentanyl decreased slightly between 2022 and 2023, they remain a major crisis. Overdose deaths involving cocaine and psychostimulants increased during the same period. Rates of drug overdose deaths for adults aged 55 and older have also unfortunately risen. A significant challenge is the treatment gap, with an estimated only one in 12 people with drug use disorders receiving necessary treatment in 2023.
For more comprehensive data and reports, see the UNODC World Drug Report 2025.
Conclusion: The Bigger Picture
While it's impossible to give a single number for how many people on average do drugs, recent data from authoritative sources reveals a landscape of increasing global drug use, particularly with cannabis, synthetic drugs, and cocaine. In the U.S., tens of millions of individuals have used illicit substances in the past month, with prevalence varying significantly by substance, age group, and gender. The overall trend indicates a persistent and evolving public health challenge, emphasizing the critical need for effective prevention, treatment, and harm reduction strategies.